Covered recipient · General Payments record
MICHAEL RAHMIN
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$7,187.22
- Reported across 80 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,500.00 | 1 |
| Food and Beverage | $334.60 | 9 |
| Education | $79.12 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $2,634.01 | 3 |
| ABBVIE INC. | $132.83 | 3 |
| Madrigal Pharmaceuticals | $79.12 | 1 |
| Merck Sharp & Dohme Corporation | $18.86 | 1 |
| Regeneron Healthcare Solutions, Inc. | $18.19 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.04 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $13.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.27 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105352585 | CMS |
| ABBVIE INC. | $113.36 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105352589 | CMS |
| ABBVIE INC. | $13.20 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105352593 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $13.67 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147022742 | CMS |
| Amgen Inc. | $107.01 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116037910 | CMS |
| Amgen Inc. | $27.00 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116037916 | CMS |
| Amgen Inc. | $2,500.00 | 11/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116037902 | CMS |
| Madrigal Pharmaceuticals | $79.12 | 10/30/2024 | Education | Undisputed | 01/23/2026 | 1144179651 | CMS |
| Merck Sharp & Dohme LLC | $18.86 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141949163 | CMS |
| Regeneron Healthcare Solutions, Inc. | $18.19 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114142321 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.04 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137658206 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.